Literature DB >> 11908776

Heart-infiltrating and peripheral T cells in the pathogenesis of human Chagas' disease cardiomyopathy.

E Cunha-Neto1, J Kalil.   

Abstract

Heart tissue destruction in chronic Chagas' disease cardiomyopathy (CCC), occurring in 30% of individuals chronically infected by the protozoan parasite Trypanosoma cruzi, may be caused by autoimmune recognition of patients' heart tissue by a T cell rich inflammatory infiltrate. Recently, our group demonstrated that T cells infiltrating the heart of CCC patients crossreactively recognize cardiac myosin heavy chain and tandemly repetitive T. cruzi antigen B13, and possess an inflammatory T1-type cytokine profile. Susceptibility factors leading 30% of infected patients to develop CCC, while the rest of the patients remain largely asymptomatic (ASY), are still obscure. We compared immunological phenotypes of CCC and ASY patients, who have distinct clinical outcomes despite bearing a similar chronic T. cruzi infection. Preliminary observations indicate that PBMC from CCC patients recognize a set of B13 and cardiac myosin epitopes distinct from that recognized by ASY patients. Moreover, the IFN-gamma response of CCC patients is more intense than that of ASY, both at qualitative and quantitative levels. Taken together, results suggest that heart damage in Chagas' disease cardiomyopathy may be secondary to inflammatory cytokines and a delayed-type hypersensitivity process started and/or maintained by heart-crossreactive T cells. Furthermore, the distinct recognition repertoire and the high frequency of IFN-gamma producing among CCC patients could be important factors leading to the differential development of CCC among T. cruzi infected individuals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11908776     DOI: 10.3109/08916930109007383

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  15 in total

Review 1.  Pathogenesis of chagas' disease: parasite persistence and autoimmunity.

Authors:  Antonio R L Teixeira; Mariana M Hecht; Maria C Guimaro; Alessandro O Sousa; Nadjar Nitz
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

2.  Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy.

Authors:  Edecio Cunha-Neto; Victor J Dzau; Paul D Allen; Dimitri Stamatiou; Luiz Benvenutti; M Lourdes Higuchi; Natalia S Koyama; Joao S Silva; Jorge Kalil; Choong-Chin Liew
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

3.  Modulation of Regulatory T Cells Activity by Distinct CD80 and CD86 Interactions With CD28/CTLA-4 in Chagas Cardiomyopathy.

Authors:  Bruna F Pinto; Nayara I Medeiros; Andrea Teixeira-Carvalho; Jacqueline A Fiuza; Silvana M Eloi-Santos; Maria C P Nunes; Silvana A Silva; Tereza C M Fontes-Cal; Mayara Belchior-Bezerra; Walderez O Dutra; Rodrigo Correa-Oliveira; Juliana A S Gomes
Journal:  Front Cardiovasc Med       Date:  2022-05-19

Review 4.  Pathology and Pathogenesis of Chagas Heart Disease.

Authors:  Kevin M Bonney; Daniel J Luthringer; Stacey A Kim; Nisha J Garg; David M Engman
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

5.  Recombinant cardiac myosin fragment induces experimental autoimmune myocarditis via activation of Th1 and Th17 immunity.

Authors:  Melvin D Daniels; Kenneth V Hyland; Kegiang Wang; David M Engman
Journal:  Autoimmunity       Date:  2008-09       Impact factor: 2.815

6.  Serum-mediated activation of macrophages reflects TcVac2 vaccine efficacy against Chagas disease.

Authors:  Shivali Gupta; Trevor S Silva; Jessica E Osizugbo; Laura Tucker; Heidi M Spratt; Nisha J Garg
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441

7.  Selective decrease of components of the creatine kinase system and ATP synthase complex in chronic Chagas disease cardiomyopathy.

Authors:  Priscila Camillo Teixeira; Ronaldo Honorato Barros Santos; Alfredo Inácio Fiorelli; Angelina Morand Bianchi Bilate; Luiz Alberto Benvenuti; Noedir Antonio Stolf; Jorge Kalil; Edecio Cunha-Neto
Journal:  PLoS Negl Trop Dis       Date:  2011-06-28

8.  Cardiac-oxidized antigens are targets of immune recognition by antibodies and potential molecular determinants in chagas disease pathogenesis.

Authors:  Monisha Dhiman; Maria Paola Zago; Sonia Nunez; Alejandro Amoroso; Hugo Rementeria; Pierre Dousset; Federico Nunez Burgos; Nisha Jain Garg
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

9.  Genetic susceptibility to Chagas disease cardiomyopathy: involvement of several genes of the innate immunity and chemokine-dependent migration pathways.

Authors:  Amanda Farage Frade; Cristina Wide Pissetti; Barbara Maria Ianni; Bruno Saba; Hui Tzu Lin-Wang; Luciana Gabriel Nogueira; Ariana de Melo Borges; Paula Buck; Fabrício Dias; Monique Baron; Ludmila Rodrigues Pinto Ferreira; Andre Schmidt; José Antonio Marin-Neto; Mario Hirata; Marcelo Sampaio; Abílio Fragata; Alexandre Costa Pereira; Eduardo Donadi; Jorge Kalil; Virmondes Rodrigues; Edecio Cunha-Neto; Christophe Chevillard
Journal:  BMC Infect Dis       Date:  2013-12-12       Impact factor: 3.090

10.  Myocardial chemokine expression and intensity of myocarditis in Chagas cardiomyopathy are controlled by polymorphisms in CXCL9 and CXCL10.

Authors:  Luciana Gabriel Nogueira; Ronaldo Honorato Barros Santos; Barbara Maria Ianni; Alfredo Inácio Fiorelli; Eliane Conti Mairena; Luiz Alberto Benvenuti; Amanda Frade; Eduardo Donadi; Fabrício Dias; Bruno Saba; Hui-Tzu Lin Wang; Abilio Fragata; Marcelo Sampaio; Mario Hiroyuki Hirata; Paula Buck; Charles Mady; Edimar Alcides Bocchi; Noedir Antonio Stolf; Jorge Kalil; Edecio Cunha-Neto
Journal:  PLoS Negl Trop Dis       Date:  2012-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.